#USA #Los Angeles #Board of Trustees #Langar Investment Management #HealthTech ETF

Langar Investment Management's Decision to Liquidate

Langar Investment Management, LLC has recently made a significant decision regarding its Global HealthTech Exchange-Traded Fund (ETF). On September 30, 2026, the firm's Board of Trustees approved a comprehensive Plan of Liquidation and Termination concerning the fund, identifiable by the ticker symbol LGHT. This strategic choice is a culmination of extensive analysis by the Adviser, focusing on the fund's asset growth, historical performance, and current investor demand.

Reasons Behind the Liquidation

The Board has concluded that discontinuing operations is paramount for maximizing shareholder benefits. Evaluating the fund's inadequacies in asset size and growth trajectory led to this pivotal decision, indicating that the liquidation aligns with the best interests of both the fund and its investors.

Timeline of Key Operations

As part of the liquidation process, several critical dates have been established:

• - Suspension of Creation Units: Effective after the close of market operations on October 28, 2026, the fund will cease accepting new orders for creation units from Authorized Participants.
• - Last Day of Public Trading: Trading shares of the LGHT fund will conclude on October 30, 2026, on the Cboe BZX Exchange, Inc. Subsequently, shares will be halted at the market's opening on November 2, 2026, followed by their delisting from the exchange.
• - Final Cash Distribution: The official liquidation date, marked for on or around October 30, 2026, will witness the distribution of remaining assets to shareholders, pro-rata in cash.

Important Notices for Shareholders

Continued Trading Until Liquidation

Shareholders are permitted to buy and sell shares of the fund on the Cboe BZX until the market closure on October 30, 2026. Traditional brokerage commissions or transaction fees might apply to such transactions.

Portfolio Transition Strategy

Leading up to the liquidation, the fund intends to begin selling off its underlying portfolio holdings, transitioning into cash or cash equivalents. During this period, the fund will not adhere strictly to its stated investment objectives and strategies as it increases its cash reserves.

Tax Considerations for Shareholders

It's essential for investors to understand that the final cash distribution will be a taxable event for shareholders with taxable accounts. Remaining shareholders will automatically receive cash in their brokerage accounts, and it is advised that they consult with tax professionals to grasp the specific tax implications of this liquidation, including any potential capital gains or losses.

About Langar Investment Management, LLC

Langar Investment Management is a subsidiary of Langar Technology, Inc. and serves as the adviser to the Langar Global HealthTech ETF. The decision to liquidate reflects a strategic pivot in the management of investment assets to better serve stakeholders moving forward.

In summary, the closure of the Langar Global HealthTech ETF is a calculated move that underlines the firm’s dedication to safeguarding investor interests while adapting to the evolving market landscape.